Logout succeed
Logout succeed. See you again!

Anaesthesia and Renal Disease PDF
Preview Anaesthesia and Renal Disease
Anaesthesia and Renal Disease Dr Cavin Gray Sheffield Teaching Hospitals Occurrence Problems associated with renal disease Pre-operative assessment Anaesthetic options Prevention of post-operative AKI Staging of chronic kidney disease Stage Description eGFR (ml/min/1.73m2) I CKD with normal GFR but other renal > 90 damage (e.g. haematuria, proteinuria) II Mild CKD and other kidney damage 60-89 III Moderate CKD 30-59 IV Severe CKD 15-29 V Established ESRF < 15 or on RRT Causes of renal failure Diabetes 25.6% Glomerulonephritis 14.0% Hypertension 7.4% Polystic kidney disease 6.7% Pyelonephritis 6.6% Renal vascular disease 6.1% Other 17.7% Uncertain 15.9% Median life years remaining for incident patients requiring RRT Aged 25 – 29 18.5 years Aged 75+ 2.4 years Overall 5 year survival on HD 30% More than 50% die from cardiovascular causes Risk of death attributed to cardiovascular causes associated with individual risk factors for anaesthesia -1 Renal failure (serum creatinine > 150 μmol.l ) on admission Age adjusted odds ratio 4.23 (95% CI 1.36 – 13.2), p < 0.013 cf previous MI 4.04 (1.6 – 10.19) p < 0.003 angina 3.55 (1.48 – 8.82) p < 0.004 heart failure requiring 2.80 (1.23 – 13.2) p < 0.014 medical treatment Howell SJ, Sear YM, Yeates D, Goldacre M, Sear JW, Foex P - risk factors for cardiovascular death after elective surgery under general anaesthesia BJA 1998; 80:14-9 Systemic effects of renal failure CVS – LVH - Accelerated atherosclerosis - Hypertension - Conduction abnormalities Respiratory - Pulmonary oedema Effects of renal failure Metabolic acidosis Altered haemostasis - platelet dysfunction - prothrombotic tendency and reduced fibrinolysis • Autonomic neuropathy - delayed gastric emptying - parasympathetic dysfunction Effects of renal failure Fluid and electrolytes - volume overload - hyperkalaemia – exacerbated by acidaemia, insulin deficiency and acute β - blockade Causes of hyperkalaemia in chronic renal disease Exogenous administration Transcellular shifts acidaemia insulin deficiency hypertonicity acute beta receptor blockade Drug effects suxamethonium, ACEI, ARBs, spironolactone, amiloride, β- blockers, NSAIDS, digoxin, spironolactone